Story perspectives

Sanofi Appoints Belén Garijo to Revitalize Leadership Amid Declines

2/12/2026

Summary

Story summary

Sanofi will replace Paul Hudson with Belén Garijo of Merck KGaA, effective April 29.
Hudson's tenure began in 2019 and included disappointing research results and frustration over Dupixent.
Sanofi's stock fell 21% last year.
Garijo previously worked at Sanofi for 15 years and aims to boost research and development (R&D) productivity and implement a more disciplined strategy.
Analysts anticipate further management changes after Hudson's final day on February 17.

1 of 1

Story summary

Sanofi will replace Paul Hudson with Belén Garijo of Merck KGaA, effective April 29.
Hudson's tenure began in 2019 and included disappointing research results and frustration over Dupixent.
Sanofi's stock fell 21% last year.
Garijo previously worked at Sanofi for 15 years and aims to boost research and development (R&D) productivity and implement a more disciplined strategy.
Analysts anticipate further management changes after Hudson's final day on February 17.